Literature DB >> 6512881

Effects of ochratoxin A in the partially nephrectomized rat.

A F Stein, S Geerling, H H Mollenhauer, L F Kubena, N D Heidelbaugh, T D Phillips.   

Abstract

The effects of ochratoxin A (OA), a nephrotoxic mycotoxin, were investigated in partially nephrectomized (PN) rats (approximately 70% reduction in renal mass) following compensatory hypertrophy of the renal remnant. Renal function stabilized 27 d after surgery. PN rats compensated for the initial loss of renal function except for glomerular filtration rate (GFR, inulin clearance); this remained significantly impaired. Sham-operated (SO) rats cleared inulin and p-aminohippurate (PAH) at rates of 3.84 and 7.49 ml/min, respectively, while compensated PN rats cleared inulin at 2.51 and PAH at 8.84 ml/min. Daily administration of low levels of OA produced decreased urine osmolality and body weight with a modest increase in urinary protein of PN versus SO rats. OA-treated rats cleared inulin, creatinine, and PAH at rates significantly lower than nontreated controls: 0.89 and 1.96 ml/min for inulin, 0.35 and 0.56 ml/min for creatinine, and 2.29 and 6.23 ml/min for PAH. Histopathological findings indicated a considerable increase in renal tubular necrosis and subcellular damage (i.e., loss of cytoplasmic ground substance, vacuolization, degeneration of mitochondria, and reorganization of endoplasmic reticulum) in PN animals versus controls, concurrent with alteration in renal function. These results verify that the nephrotoxic action of OA is elicited mainly in renal proximal tubules and is enhanced in the PN rat.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6512881     DOI: 10.1080/15287398409530604

Source DB:  PubMed          Journal:  J Toxicol Environ Health        ISSN: 0098-4108


  1 in total

1.  The mycotoxin ochratoxin A deranges pH homeostasis in Madin-Darby canine kidney cells.

Authors:  M Gekle; R Vogt; H Oberleithner; S Silbernagl
Journal:  J Membr Biol       Date:  1994-05       Impact factor: 1.843

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.